[Results of combined chemotherapy of lymphosarcoma with cyclophosphamide, vincristine and prednisolone].
The effectiveness of treatment of lymphosarcoma of lymph nodes with cyclophosphamide, vincristin (oncovin) and prednisolone (scheme COP) was found to depend on the cytomorphological type of tumor, stage and previous therapy, with duration of remission being in direct correlationship with its degree.
D000971:Antineoplastic Combined Chemotherapy Protocols; D003520:Cyclophosphamide / Q000008:administration & dosage* / Q000009:adverse effects; D004359:Drug Therapy, Combination; D006801:Humans; D007970:Leukopenia / Q000139:chemically induced; D008206:Lymphatic Diseases / Q000188:drug therapy*; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy*; D009367:Neoplasm Staging; D011241:Prednisone / Q000008:administration & dosage* / Q000009:adverse effects; D014750:Vincristine / Q000008:administration & dosage* / Q000009:adverse effects
D014750:Vincristine; D003520:Cyclophosphamide; D011241:Prednisone
Rezul'taty kombinirovannoĭ khimioterapii limfosarkom tsiklofosfanom, vinkristinom i prednizolonom.